Swedish-born Skype co-founder Niklas Zennström runs Europe's largest founder-led venture firm — Atomico, $5.5B+ AUM across six funds. Germany is Atomico's largest single non-UK/Nordic market. Berlin is one of four Atomico offices. DeepL is the flagship current bet. Lilium was the most expensive write-off in the firm's history. Inside the Bundestag's €50M loan refusal that killed Munich's electric-aviation pioneer and why a Swedish patriarch built his German position.

Bavarian-born Andreas von Bechtolsheim is the most successful German in Silicon Valley — net worth $31–35 billion, #5 richest German globally, the man who wrote Google's first $100,000 check. He is also the quietest. Inside his DACH deep-tech portfolio — KONUX, Black Semiconductor, USound, LiveEO — the Hermann Hauser co-invest pattern, and why he is the operating opposite of Peter Thiel.

Frankfurt-born Peter Thiel publicly championed European defense tech for years before the consensus shifted. The German defense wave he forecast just produced its biggest winner — Helsing at $18B — and it's not in his portfolio. Inside the 15-company DACH position, the Trade Republic anchor, the STARK Defence bet, and the structural friction Germany has with the man whose capital its founders happily take.

He built SAP's North American business, exited in 1997 for DM 1.6B, then spent 30 years constructing Germany's STEM and AI talent pipeline.

Hopp turned SAP wealth into permanent regional infrastructure — KiTZ, neonatal screening, 19 public parks, biotech anchor capital. Not charity. Capability.

52 years inside SAP. Three architectural bets. Europe's most important software founder. The story of how Hasso Plattner built — and held — the platform.

Claus Wellenreuther died March 21, 2026, age 91. He built SAP's financial accounting module, exited in 1980, founded the alternative — and SAP bought it back.

What the Strüngmann brothers are funding now — Antheia, AAVantgarde Bio, Doctolib, Immatics, Tubulis — and what it signals about the next decade of DACH biotech.

Why Athos Service — the Strüngmann brothers' Munich family office — outperforms US-style venture capital on deep-tech bets like BioNTech.

The 2005 Novartis-Hexal deal made the Strüngmanns' fortune — but more importantly, it taught them how to recycle one exit into the next BioNTech.

From Hexal's €5.65B Novartis exit to BioNTech's $50B+ peak — how Andreas and Thomas Strüngmann built the architect-class behind DACH biotech. Inside the Athos Service playbook.

Europe is not short of scientific founders or early capital. It is short of the specific combination that produced BioNTech: patient anchor capital plus state co-financing plus a global commercial partner, sustained over a decade, without forcing the founder team to relocate to the US. That combination still exists in DACH only by accident. Until it exists by design, BioNTech remains a one-off rather than a model. Executive summary Europe has world-class scientific founders,

Founders who reach platform-scale success face a structural problem: the company they built can no longer execute the science they want to do. Şahin and Türeci's planned 2026 spin into a new mRNA company is the engineered answer — separate frontier research from commercial discipline, retain agency, keep economic exposure through BioNTech's planned minority stake. It is the rarest move in European deep tech because it requires founders who own the cap table to design it. Intr

The popular framing that BioNTech "got lucky with COVID" collapses under the timeline. The company was incorporated in Mainz in 2008 with cancer immunotherapy as the founding thesis, was anchored by Strüngmann patient capital years before any pandemic, and had already attracted a 2019 Gates Foundation investment for HIV and tuberculosis programs. The vaccine was the visible breakthrough; the bet was twelve years old. Introduction The anchor piece argues that BioNTech is a pow

Uğur Şahin and Özlem Türeci's planned 2026 transition out of BioNTech management to lead a new mRNA company is a rare European founder act-two — engineered with cap-table control, BioNTech as minority stakeholder, and patient German capital underneath. The vaccine was the visible breakthrough; the founder pattern is what DACH should be studying.

The EU's €40 billion Innovation Fund has deployed less than 1% of its budget after five years. A Startuprad.io analysis of what the European Court of Auditors' 2026 audit reveals for DACH deep tech founders, VCs, and cleantech investors — and what comes next with the €451B European Competitiveness Fund.

ost-read ads became Germany’s most trusted ad format in 2025 because human voices outperform automation. 92% of podcast listeners accept ads, 75% trust their favorite hosts, and these voice-based endorsements deliver 35% higher recall than programmatic placements. Germany’s transparency rules and strong media ethics turned podcasting into the continent’s credibility benchmark.

Aleph Alpha becomes Germany’s sovereign-AI platform as Lidl-owner Dieter Schwarz and the Schwarz Group fold it into their STACKIT cloud, turning frontier research into enterprise-grade, compliant infrastructure.

Startuprad.io is Europe’s leading startup podcast, ranked among Germany’s Top 100 Podcasts. From Frankfurt to the world, it connects founders, VCs and policymakers — and now powers the ecosystem with an AI Concierge that turns a decade of interviews into verified startup intelligence.

The DACH Startup Ecosystem 2025 Hub is your all-in-one source for startup news, VC trends, unicorn trackers, and regulatory insights across Germany, Austria, and Switzerland. Discover monthly funding data, policy updates, and exclusive deep dives into AI, fintech, and cleantech shaping Europe’s innovation economy.